If GLP-1 inhibitors were a book, we would likely be in the second chapter. Used for almost two decades in the treatment of diabetes, the drugs have made the condition much more manageable for patients worldwide.
Arguably, they represent the first major pharmacological advancement towards preventing type 2 diabetes; a disease that threatens to cripple healthcare...